Clinical trials of tirzepatide have reported average weight reductions exceeding 20% of body weight in some patient groups, making it one of the most powerful pharmaceutical tools currently available for fat loss
[2] This approach allows the gastrointestinal system to adapt progressively to the medication's effects
3 Both results significantly exceeded those achieved in clinical trials with medication alone, suggesting that appropriate support may enhance outcomes
This overview is educational, not medical advice, so anyone considering a peptide regimen, prescription or non-prescription, should consult a licensed healthcare provider to confirm it's appropriate for their health history
In particular, retatrutide, a triple agonist targeting GLP-1 receptors, GIP, and glucagon receptors, has demonstrated substantial metabolic benefits, raising interest in its potential for treating substance use disorders as well (Jastreboff et al